Healius Limited (HLS)

Index:

ASX 100

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.70
  • Currency: Australian Dollars
  • Shares Issued: 521.92m
Select chart: 1 month | 6 month
 

Current

1 month

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-26 1,403.48 46.68 1.82¢ 44.2 n/a -92% 0.50¢ 0.0%
30-Jun-27 1,463.26 68.48 4.03¢ 20.0 0.2 +121% 1.71¢ 0.0%
30-Jun-28 1,526.68 83.35 5.36¢ 15.0 0.5 +33% 3.52¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-26 $2.69 0.30
30-Jun-27 $2.80 0.29
30-Jun-28 $2.93 0.28

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2026 1,404 n/a 1,404 n/a 1,414 n/a
30-Jun-2027 1,463 n/a 1,464 n/a 1,479 n/a
30-Jun-2028 1,527 n/a 1,528 n/a n/a n/a
 
Earnings
30-Jun-2026 1.82¢ n/a 1.66¢ n/a 2.52¢ n/a
30-Jun-2027 4.03¢ n/a 3.62¢ n/a 4.03¢ n/a
30-Jun-2028 5.36¢ n/a 5.05¢ n/a n/a n/a
 
Dividend
30-Jun-2026 0.50¢ n/a 0.40¢ n/a 1.77¢ n/a
30-Jun-2027 1.71¢ n/a 1.71¢ n/a 2.65¢ n/a
30-Jun-2028 3.52¢ n/a 2.88¢ n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 1 0 1 0 0 0
Neutral 4 0 5 0 4 0
Sell 6 0 7 0 8 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 11 0 13 0 12 0
 
Average Rec 3.86 n/a 3.85 n/a 3.33 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

HLS Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.70
Shares Issued 521.92m

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 4
Sell 6
Strong Sell 0
Total 11
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page